Ligand validation:6MVV

PX4: 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE

PX4 is a Ligand Of Interest in 6MVV designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MVV_PX4_C_1301	40%	39%	0.21	0.963	1.28	1.13	3	3	12	0	78%	1
6MVV_PX4_A_1301	35%	43%	0.224	0.972	1.09	1.1	2	1	9	0	67%	1
6MVV_PX4_D_2301	32%	35%	0.229	0.965	1.38	1.18	3	2	4	0	67%	1
6MVV_PX4_B_2301	26%	37%	0.252	0.955	1.16	1.33	3	2	8	0	65%	1
6MVV_PX4_C_1302	25%	48%	0.214	0.943	1.22	0.8	2	1	4	0	48%	1
6MVV_PX4_B_2302	23%	41%	0.271	0.941	1.18	1.1	3	2	4	0	74%	1
8DJ0_PX4_A_1301	65%	83%	0.148	0.949	0.31	0.46	-	-	2	0	100%	1
3RW0_PX4_A_4002	63%	49%	0.072	0.983	0.93	1.03	1	1	0	0	35%	1
6MWD_PX4_B_2301	58%	44%	0.165	0.945	1.03	1.15	4	3	7	0	100%	1
6MWA_PX4_B_2301	55%	41%	0.149	0.944	1.09	1.21	4	4	10	0	85%	1
8DJ1_PX4_A_1301	54%	89%	0.18	0.954	0.28	0.36	-	-	1	0	96%	1
6MWG_PX4_B_2301	53%	42%	0.161	0.939	1.08	1.17	4	2	6	0	91%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.